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biology, psychiatry, physiology, econometrics etc., concerning
behavioral investigations of such organisms, it is extremely
difficult, if not impossible to find absolute and universally valid
laws. Even in cases where the focus is on specific behavioral
characteristics or alterations, we have to spend immense time and
effort to explain them well and adequately. The required expense
would be even larger if the topic of these investigations is the most
intelligent and complicated biolog ical organism on earth, to wit
the human being.
Being aware of the enormous complexity of higher biological
organisms, scientists who investigate biological phenomena hope
to identify those influential factors, that are able to characterize
disturbed or extraordinary behavioral changes. The search for
such relevant influential factors, known in the broader sense as
‘biomarkers’, is, therefore, an essential objective of almost all
modern biological studies. This search, however, is not only from a
biological but also from a statistical point of view a challenge per
se.
It is well-known that the Achilles heel of the statistical inference
is the hypothesis-testing via a statistical test. This is in principle a
decision process (see [1]) of choosing between two possibilities (null
versus alternative hypothesis) and the result of it like any decision
may be either correct or incorrect. An incorrect decision in the
statistical inference is associated with two risks known as Type I
and II errors and denoted with the Greek letters a and b,
respectively. Type I error is the risk of rejecting the null hypothesis
when it is true, and type II error is the risk of accepting the null
hypothesis when it is false. Close connected to the statistical
inference is also the test power or simply, power. Test power
denotes the ability of a statistical test to reject a false null

Introduction
Biomarker Searching: The statistical challenge of clinical
and preclinical basic research
There is no doubt that the more facets of a complex
phenomenon we can illuminate, the better we can explain the
structure, mechanisms and alterations of this phenomenon. On the
other hand, art of science is the ability to configure and describe a
complex phenomenon with as few variables as possible but with a
sufficient degree of detail, in order to make it comprehensible,
plastic and operational. Therefore, when studying complex
phenomena we must sail in both directions: firstly, to collect as
much information as possible in order to explain the phenomena
adequately and, secondly, to reduce the data abundance
appropriately by identifying the most informative variables.
Obviously, the restriction to the most informative data or to the
most relevant factors that influence a complex phenomenon
implies the renunciation of its complete and perfect explanation.
At the same time, however, this restriction allows for a great gain
in attractiveness and plasticity and makes such a complex
phenomenon useful for practical simulations and further scientific
investigations.
Higher biological organisms generally possess complex structures and are characterized by extreme intra- and inter-individual
variability. This variability is not only due to thousands and
thousands of genetic and epigenetic factors, but also to the fact that
many of these factors vary with time, location and situation.
Therefore, approaches to explain structures and behavioral
mechanisms of biological organisms are of a difficult nature.
Without exaggeration, we can ascertain, that in sciences, e.g.
PLoS ONE | www.plosone.org
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hypothesis, or in the case of a location test, its ability to detect true
differences. From the definition of Type II error it follows that the
test power is equal to 1{b.
But what are true differences and at which amount may they be
declared relevant? In biomedical research one uses for the mean
differences between two populations the term biological difference.
The meaning and amount of biological differences are the basis for
contention in many scientific conflicts. Here exist no unambiguous
and clear answers. The amount of differences that have to be
declared as relevant depends on many factors, e.g. on experimental and financial requirements, on the data types and scales, on
sample heterogeneity, etc. Therefore, a great arbitrariness exists in
the definition of relevant differences and just this arbitrariness
extenuates the generalization of statistical inference to more
complicated situations, for example, when more variables,
different scales, more or multilevel factors exist.
Researchers behind basic-research investigations are not
disposed to retrench scientific hypotheses concerning only one or
a few variables. For scientists in this field all considered variables
are a-priori important and, therefore, they relate their scientific
assumptions to all of them, even in cases where some of the
variables are declared as primary variables. Naturally, they hope
to detect via statistical methods those few relevant variables or
features that are interpretable, can help to explain well the
variability of the investigated phenomenon and parallely could
contribute to a reduction of noise effects and computational costs.
A simple way in such situations is to postulate a complete or
omnibus statistical hypothesis, taking into account all variables and
selecting relevant variables by making statistical inference for each
one of them on the basis of a procedure similar to multiple testing.
Generally, statistical inference on a large number of variables is
questionable, especially when the variables are measured in
different scales and/or show dependencies (see e.g. [2]). Even
under the assumption of independence and with the use of a
uniform metric scale, statistical inference of multivariate data is
liable to two risks: an inflation of the type I error and a deflation
(weakness) of the overall power. To keep these risks small one has
to strongly correct the level of significance and simultaneously
operate with large sample sizes. The last task is usually not possible
and strong corrections of the level of significance imply a very
conservative detection procedure. This means, a lot of variables
contributing to the explanation of an observed phenomenon may
fail to be statistically significant and remain uncovered. Another
way favored by some modern approaches (see more details in the
discussion) make use of association models and pass thereon to
variable selection and dimensional reduction. However, these
approaches are also not completely free of statistical inference.
When hypothesis testing is focused to a-priori defined subset of
variables or factor levels, a noteworthy suggestion in the field of
statistical inference is to refer to a partial null hypothesis and to
partial or P-subset power (see e.g. [3] or [4]). But how can we
know a-priori which e.g. genes are influenced by a disease?
Therefore, the only promising solution in searching for biomarkers
by complex biological investigations is a selective statistical
inference applied to an adequate partial statistical hypothesis that
concerns only of few of the most relevant (informative) variables
detected in advance. The conception of an appropriate exploratory method that leads in an uncomplicated and reliable way to
the identification of the most informative variables (biomarker
candidates), independently of sample type, data nature, distribution requirements and so on, is the work and the challenge
discussed below.

PLoS ONE | www.plosone.org

Methods
A new ‘distribution-free’ approach
We focus on the detection of relevant biomarkers in the twosamples situation, which implies an influential factor of two levels
(two groups, two treatments, two time points, two experimental
conditions, etc.). The generalization to more complicated situations and more factors is discussed in the end of this section.
Following list summarizes the desired properties of the new
method:

N
N
N
N

Avoidance of statistical inference
Possibility to also work in cases where there are strong
dependencies between variables (collinearity, interactions)
Applicable to different data types (metric, ordinal, categorical)
and to different scales of measurement
Applicable to different experimental designs

How does the new method work in order to accommodate these
requirements?

Measure of Relevance
Let us first address the question of which kind of information
might be relevant in describing the difference of a variable in a
two-sample problem and why. The graphs in figure (1) help us find
the answer convincingly and objectively. Figures (1a), (1b) and (1c)
represent three possibilities for the distributions of two continuous
random variables, X1 and X2 , from two independent samples. The
distributions of X1 and X2 have identical shape in figures (1a) and
(1c), however, the difference between their mean locations is larger
in figure (1a). Because of the different degree of overlap a
comparison of X1 and X2 by means of a nonparametric test would
yield a smaller p-value for the situation in figure (1a) than for that
in figure (1c).
The distributions from figure (1a) differ from those in figure (1b)
in shape as well as in location. The difference of the mean location
in situation (1b) is larger than that one in situation (1a). In
biomedical research one would speak of a larger biological
difference in the case of (1b). If we consider, at the same time, the
different variability degree of the variables and form the
normalized biological difference, i.e. the ratio of observed
difference and pooled standard deviation, the situations depicted
in figure (1a) and (1b) might not be so different after all.
Figures (1d) and (1e) depict two situations for dependent
samples. Obviously the mean differences for the two groups in
figure (1e) are large compared to those in (1d). However, when
applying a nonparametric test for dependent samples one will
obtain significant results (small p-values) for both situations,
although location and deviation of the two situations differ
essentially from each other.
Summarizing the facts, from the above comparisons, we
conclude that an adequate quantitative measure or function that
would contain or reflect relevant information about sample
differences in a variable, must maintain the following properties:

N
N
N
N
2

it should incorporate a possible overlap in the distributions of
the two samples
it should express the biological difference on a uniform scale, at
best on the interval ½{1,1
it should incorporate the variance of the biological differences
in an inverse relation in order to attenuate the effect of
different metric scales on the biological difference
it should incorporate the corresponding sample size in an
inverse relation. This property will accommodate situations
May 2012 | Volume 7 | Issue 5 | e35741
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Figure 1. Example of different distributions of two random variables. Location and shape of two independent (1a, 1b, 1c) and two
dependent random variables (1d and 1e).
doi:10.1371/journal.pone.0035741.g001

approximates the sample values yi , we first search for a function
F (X(j) ,=), which for each feature (variable) j (j~1,2,:::,p) delivers
important information about its differences between the two
groups and then look for the features with the largest information
values. We assign the wanted function F (X(j) ,=), the name
‘measure of relevance’ (MoR). Therefore, the principle of the new
method is not to search for the best classifiers, that enable optimal
fitting in a sample, but rather to search for the best informators
that give the best information over a sample’s irregularities and
distinctive characteristics. In a mathematical notation this
principle could be outlined in three steps:

with missing values as well the fact that when sample sizes
increase the probability of detecting small effect sizes as
relevant should also increase

The principle of the new method
In a two-groups situation let
=~f(Xi ,yi ),Di~1,2,:::,ng

ð1Þ

be
h a sample of n items, ion each of which a vector Xi of p features
Xi ~(Xi(1) ,Xi(2) ,:::,Xi(p) and a group-membership variable yi ,

N

½yi [fk1 ,k2 g are considered.
In decision tree analysis, like CART (Classification And
Regression Trees), Random Forest, AdaBoost, etc. (for an
overview see [5]), which offer, in the explorative field, powerful
ways to detect significant features and associations between them
and the group variable, one generally searches for a function
f (Xi ,=) over the feature vectors Xi , which fits the observed group
variables yi ,i~1,2,:::,n in the sample well. In mathematical
notation it means that f (Xi ,=) has to fulfill the condition:
e= ~

Xn
i~1

N
N

Dependencies between the features are in the first instance not
of particular interest, because we are primarily focused on
identifying features with information about the group difference
and not on dependencies between features. Only after identifying
features with relevant information (biomarker candidates) would it
be advisable and interesting to further study dependencies between
them and the other features.
Considering the aforementioned desired properties of a
quantitative and informative measure towards sample differences,
we find that a function, say F , of form

(yi {f (Xi ,=))?min:

where e= indicates the total prediction error.
The growth of the decision trees uses algorithms which
determine by successive steps the best split-variable (feature) and
its best splitting-value that could further improve prediction.
Although greedy algorithms are very ingenious and fast, we can
imagine how laborious decision tree analysis could be if p is very
large (pww20,000). Moreover, when the two groups represent
two dependent samples the fitting of f (Xi ,=) creates additional
difficulties.
By our method we digress from the fitting principle used in the
decision-tree analysis and follow another one working as follows:
Instead of searching for a function f (Xi ,=) over the p features that

PLoS ONE | www.plosone.org

definition of a function F (X(j) ,=) reflecting for all features j
(j~1,2,:::,p) relevant information about the group or sample
differences
construction of an information chain by sorting the absolute
values of F (X(j) ,=) over j
definition of a selection- and evaluation criterion on the
information chain

F (X(j) ,=)~g:

C (j) :L(j)
,
S(j)

ð2Þ

where C (j) ,L(j) and S(j) represent indicators for the distributionoverlap, the biological difference and the standard deviation of the
pooled sample, contains the most useful information about the

3
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differences in feature j between the two samples. g in the above
formula indicates a weighting factor common to all features.
To meet the method’s requirements (listed at the beginning of
this section) the factors C (j) ,L(j) and S (j) , which have to be
determined from the sampled data, must have on F (X(j) ,=) the
same range values for all features j irrespective of the data type
and sample design and guarantee comparisons in F between
features and/or between other samples. A good way to supply F
with these properties offers the rank- and U-transformations
applied in succession. For each feature j,(j~1,2,:::,p) we first
transform its values in the whole sample into ranks, say R(j) , and then
transform the corresponding ranks into the interval ½0,1 by using
R(j) {R(j)
min
the formula U (j) ~ (j)
. In the end we obtain a new
(j)
R
{R
max
min
sample
Ł ~f(Ui ,yi ),ji~1,2,:::,ng

The expression in the right of (7) is identical to the statistic used
for the parameter comparison of two binomial distributions when
n1 and n2 are large (see [6]). We use this formula for the
calculation of MoR irrespective of sample size by differentiating
between sample designs only. According to the underlying sample
designs the p(j)
m (m~1,2) have to be determined differently.
Formula (8) means the following: For independent samples, p(j)
1
and p(j)
2 in the above formulas represent the proportions of the
transformed data U (j) in the sample Ł that are larger than the
n1
. Since for the
quantile ~
u(j)
q of the pooled sample, where q~
n1 zn2
feature j, U (j) represent transformed values of consecutive ranks in
the interval ½0,1 we can find after some algebra that ~
u(j)
q is equal to
uq equals the median of the pooled sample,
q for any j. For n1 ~n2 , ~
which is here 0:5.
(j)
For dependent samples p(j)
1 and p2 refer to the proportion of
positive or negative differences, respectively. Ties will not be
considered. Since for dependent samples n1 ~n2 , it is easy to
conclude that p(j) is here equal to 0:5 for any j.
Substituting the factors C (j) ,L(j) and S (j) in formula (2) with the
related expressions of (5)–(8) concerning to transformed data and
1
setting for the weighting factor g~ pﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ we obtain for
(n1 zn2 )=2
each feature j,(j~1,2,:::,p) of the original sample = the
corresponding MoR. The complete and compact MOR-formula
looks so:

ð3Þ

with Ui ~(Ui(1) ,Ui(2) ,:::,Ui(p) ).
Now let
Ł km ~f(Ui ,yi ),Di~1,2,:::,nm g

ð4Þ

denote the two subsamples of Ł with values Ui corresponding to
the group km (m~1,2). For dependent samples n1 ~n2 ~n=2.
Based on the samples Łkm , (m~1,2) the factors L(j) , S(j) and
(j)
C in (2) are defined as follows:
L(j) ~(Uk(j) {Uk(j) )
1

2

rﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
S (j) ~ s2 (j) zs2 (j) {2s (j) (j) ,
U
k1

where Uk(j)m , s2 (j) and s
U
km

U
k2

(j) (j)
U U
k1 k2

U U
k1 k2

ð5Þ

(j)
jp(j)
1
1 {p2 j
MoR(j) ~ pﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ : rﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
1
(n1 zn2 )=2
p(j) :(1{p(j) ):( z )
n1 n2

ð6Þ

 (j) {U
 (j) )
(U
1
2
: rﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
s2 (j) zs2 (j) {2s (j) (j)
U
k1

(j)

If we ignore the index j, (j~1,2,:::,p) and focus on one feature
(variable) only, the formula of the MoR looks very simple. This
formula is shown in Appendix S1 and can be used in calculation
software programs for an easy determination of the measure of
significance via algorithms.
Please note, while the L(j) ’s are unbiased estimators of the
difference between population means, S (j) ’s are not unbiased
(j)
estimators of the pooled standard deviation. The factors LS(j) that
represents the normalized biological differences are similar to the
Hedges’ g (see [7]). However, g is an unbiased estimator of the
effect size only by a multiplication with a certain factor. Besides
Hedges’ g there are further estimators of effect size, for example,
Cohen’s d (see [8]) or Glass’ D (see [9]) as well as other
correlational effect-size indicators. Most of these effect-size
L(j)
indicators which include the factors (j) are characterized with
S
small-sample biases. Nevertheless, provided that we are predominantly interested in an adequate measure of the information
content and not in the development of a statistic and its
distribution, the question of optimality and unbiased effect-size
estimators does not affect the new method substantially.

U U
k1 k2
(j)

In contrast to the definitions of L and S , which are valid to
any data type and any sample design, the definition and
determination of C (j) (j~1,2,:::,p) needs to differentiate between
dependent and independent samples. By using the indicator I(z)
which equals 1 if z is true and 0 elsewhere, we define C (j) as
follows:
(j)
Dp(j)
1 {p2 D
C (j) ~ rﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
1
p(j) :(1{p(j) ):( z )
n1 n2

ð7Þ

(j)
n1 p(j)
1 zn2 p2
and
n1 zn2

9
8X
nm
1
n1
>
>
>
I(Ui(j) §
), for independent samples >
>
>
>
>
>
>
nm
n1 zn2
>
>
>
>
=
< i~1
(j)
n=2
ð8Þ
pm,( m~1,2) ~ X
1
>
>
>
(I(U1i(j) {U2i(j) ) inq 0), for dependent samples >
>
>
>
>
>
>
n=2
>
>
>
>
;
: i~1
where inq refers to 0 w’ for m~1 and 0 v’ for m~2

PLoS ONE | www.plosone.org

U U
k1 k2

denote means, variances and

covariance of the Uk(j)m over the samples km , (m = 1,2; j = 1,2,…,p),
respectively. For independent samples s (j) (j) obviously equals 0.

where p(j) ~

U
k2

ð9Þ

Notes
(a) Categorical data. Using the transformed sample values
U (j) instead of the observed data values and determining therewith
the unknown parameters in (9) we are able to calculate the
measure of relevance for almost all common situations in a two
4
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sample-problem, namely for dependent or independent samples
and for metric, ordinal and binary data as well, when binary data
are coded by the numbers 0 and 1. Exceptional situations may
expose only nominal data with more than two outcomes. Of
course, nominal data can be handled as ordinal categorical data
too, but assigning numbers to their outcomes is an arbitrary act.
However, for nominal data with more than two categories, this
process should not be pursued. In reality we deal with multinomial
distributions, and the transformation of their location and
dispersion parameters into an one-dimensional parameter, like
the measure of relevance, creates some difficulties. Provided that
the sample sizes are sufficient, we suggest not considering nominal
variables as predictors, but rather as influential or control
variables.
(b) Avoiding ties in MoR. When operating with very small
sample sizes and very large numbers of continuous variables,
which for example is often the case in gene expression analyses, it
is recommendable to use the original data to calculate L and S in
formula 2 rather than using ranks and U-transformations. This is
because for very small sample sizes the use of ranks and Utransformations will often produce normalized biological differences L=S with equal values (ties) (It is easy to understand
that the


(n1 zn2 )
number of possible values of L=R is equal to N : ~
).
n1
Also, N will be the maximal number of different MoR values,
since the factor C in 2 is transformation-invariant. In these cases,
the discriminative power of MoR suffers and the only way to avoid
this shortcoming is to operate with the original values. By doing so
we take the risk of outlier effects which we accept, since clearingup outliers is not particularly useful in very small samples.

variables to the set. We stop adding variables to the set as soon as
the change of entropy becomes negligible.
The following formula measures the adjusted change of entropy
when adding the variable with the next smallest relevance value.
Dj E~

N

Sort the absolute MoR-values of the variables X1 ,X2 , . . . ,Xp in
decreasing order. X½1 , . . . ,X½p denote the corresponding
ordered variables. Choose the first variables X½1 , . . . ,X½k
whose corresponding absolutePMoR-values (dj ) fulfill for the
k

dj

first time the condition d  ~ Pj~1
§d, where d indicates a
p
j~1

N
ð10Þ

dj

number less than 1. It is required that the information of the
first k selected variable must be at least equal to a predefined
fraction d of the information supplied by all features.
Choose a constant less than 1, e.g. c~0:10, that will represent
a proportion of the total number of desirable informative
variables and choose the c:p variables with the largest absolute
MoRj .

(d) Cut-off criteria: Sample-related objective cut-off
criterion

j~1

2:45:h
Choose all variables with dj § pﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ,
(n1 zn2 )=2
where h is a weighting factor equal to 0:2,0:5 or 0:8 for small,
moderate or large effects (see e.g. [8]). It is noteworthy that small,
moderate or large effects should be desirable with large, moderate
or small sample sizes corresponding to less than 30, between 30
and 60 or more than 60 observations in both samples, respectively.
Since for large samples the factor C (j) tends to increase (because its

N

By sorting the absolute MoR-values of the variables
X1 ,X2 , . . . ,Xp in decreasing order, we build m sets of variables,
the first set, K½1 containing the variable X½1 with the largest
relevance value (first value of the information chain), the second
set, K½2 containing variables X½1 and X½2 with the two largest
relevance values and so on. For each of the sets we determine the
entropy amount E. This value grows by adding more and more
PLoS ONE | www.plosone.org

ð11Þ

Therefore, when the condition Dj Eƒe, where e indicates a very
small number, is for the first time fulfilled by the index j  , all
variables in the information chain with index less than j  should be
selected as informative.
(b) Permutation distribution. Another way to identify the
number of relevant variables could be created by a permutation
procedure.
For this purpose the group variable is permuted to derive a
random group assignment among the observations. Thereby
attention has to be paid that the original sample sizes remain stable
for all permutations. Based on any new random grouping, we
conduct the calculation of the relevance measure for all considered
variables. The permutation procedure and calculationof the MoR

(n1 zn2 )
under random group assignment is repeated N : ~
n1
times. By exhausting all possible permutations, we obtain for each
variable N MoR-values. We then determine for each variable
among its N MoR-values a p -interval containing its N :p greatest
MoR-values, where p may be equal to a corrected or uncorrected
a, according to scientist’s choice. Variables whose observed MoRvalue are within the p -intervals should be declared as relevant.
We made us aware of that for the selection of informative variables
by means of permutations we do not implicitly want the
information chain. However, to avoid too many calculations with
the permutation method, it is advisable to focus only on variables
that are at the first fragment of the information chain when MoR’s
are sorted in decreasing order.
(c) Cut-off criteria: Subjective cut-off criteria. By this
approach, we are considering the following cut-off criteria:

After receiving the MoR’s for each feature j, (j~1,2,:::,p) and
constructing with their absolute values the information chain over
j in the 2nd step, we then have to go to the last step of our method,
which is to define a suitable selection and evaluation criterion in
the information chain. We give below several selection criteria
which help to determine the extent of relevant variables.
(a) Entropy. We are using entropy as a metric which
describes the mean information content of a set of variables. It is
a function which depends on the total number of variables in the
considered set and the according relevance measure values.
Changing the content of the set leads to a change in the entropy.
Let us assume that the set consists of k variables Xj , (j~1,:::,k)
with kvvp (: ~ number of all considered variables), each of
them featuring an information content of size dj . In our case, dj
corresponds to MoR of the variable Xj . Assuming equal
probability for all variables to be chosen as relevant, the entropy
of the set of variables of size k is given by

j~1

j~2,:::,p:

r~1

Selection Criteria


0
1




X
k
B
C
xj : B xj C

Ek ~
lnB k C
k
 j~1 P
@ P A

x
xj 
j


Ej {Ej{1
,
j
P
Er

5

May 2012 | Volume 7 | Issue 5 | e35741

Identifying Biomarkers in Biomedical Research

denominator decreases), the weighting factor h acts as a pedant
and braking factor to the C (j) ’s. The number 2:45 is indeed a
product of simulations, but it can also be derived after some
(j)
consideration. Because the factor LS(j) looks like to a Z-statistic, we
expect that for large samples it will also have similar properties to
this statistic. The 5%- and 20%-quantiles of the standard normal
distribution give together about 2:45. Compared to the entropy
criterion the cut-off criteria are easy to conduct.
An interesting question regarding the stop-criteria is how to
proceed with thse criteria as an optimal way to detect relevant
biomarkers? After creating the information chain with the
relevance measures of the considered variables it is recommended
to first deal with an objective criterion that facilitates the decision
of whether the information chain indeed contains informative
variables or not. For this purpose, a good objective criterion is the
sample-related objective cut-off criterion mentioned above. When
the maximal absolute MoR-value in the peak of the information
2:45:h
chain is less than pﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ, then the absolute MoR-values of
(n1 zn2 )=2
all other variables will also be less than these criterion-barrier. This
implies that none of the investigated variables are informative. In
such a case we do not want to make any further effort for the
detection of biomarkers. However, if we find variables along the
information chain with absolute MoR-values greater than the
corresponding threshold, then the search for biomarkers should be
continued as follows:
If the number of variables whose relevance measure is greater
than the criterion-barrier is too large then it is advisable to further
use some subjective cut-off criterion to reduce the selection of the
informative variables into a desirable amount. Again: an objective
stop criterion should not be considered the ultimate ratio for
selecting the most relevant biomarker candidates. In many
situations we have to align the amount of the relevant biomarkers
to practicability requirements and not to those of the stop criteria,
independently of how objective the latter are. When, for example,
in investigating allele frequency-distribution for 300,000 SNPs
(single nucleotide polymorphism) between two sample populations
we find, by a selection criterion, 300 or more relevant SNPs, it
would be impractical to consider all these SNPs as biomarker
candidates for further analysis, especially not in cases with
comparatively small sample sizes.

simulation runs with different sample sizes. All variables (informative or not) are derived from the same distribution, but with
different parameters, in order to assign them the desirable degree
of information. If the MoR enables the identification of
informative and non-informative variables correctly, independent
of data structure, sample size and sample design, then the
objectivity of the measure of relevance is highly guaranteed.
Reliability is more or less the answer to the question of how
good a measure or metric scale can bear up against the practical
test. In some scientific disciplines, where scales concern subjective
assessments, reliability is often evaluated with agreement-coefficients of interrater or repetitions or intrarater scores. However,
our measure of relevance concerns objective data, therefore, we
need different instruments to test reliability. An appropriate
method to proof reliability of the measure of relevance is the
evaluation of its ability to identify relevant biomarkers in different
situations (when the two samples derive for example from different
distributions). To do so we simulated three different two-sample
situations with 1,000 variables derived from a normal, uniform or
a bimodal distribution, respectively. Also, 10 of the 1,000 variables
have high, moderate or negligible information content.
The question of whether the informative variables are indeed
informative is verified by the validity test. To test the validity of
MoR we compared the results from established statistical methods
(see below) with the measure of relevance. These methods were a)
the Random-Forest approach working on the explorative level and
b) the multiple-testing procedure based on non-parametric tests
(U-tests, Wilcoxon-tests or Sign-tests) working on the confirmatory
level.

Results
(a) Objectivity
Table 1 gives a survey of the simulation results and delivers a
better and deeper insight into the objectivity of the measure of
relevance. When the ten exceptional variables are highly
informative the simulation runs delivered, for both sample designs
and both data structures (metric or binary), very good to excellent
identification rates (95{100%), irrespective of sample sizes. This
means, that the measure of relevance is capable of identifying
almost exactly the 10 selected, very informative variables.
Therefore, the measure of relevance shows a high sensitivity.
When the 10 considered variables were semi-informative and have
a normalized biological difference near 1 we can not expect that
all of them will prove as informative in the simulation runs.
Depending on the sample sizes, the part of the 10 variables that
can be identified as relevant in view of information content varies
from moderate (50{60%) for small samples to high (90{100%)
for large sample sizes. Because we are not able to know a-priori
which of the 10 semi-informative variables are indeed informative,
in each case we applied an appropriate non-parametric test. Those
variables among them with p-values less than the adjusted a,
a ~0:005 are considered informative. Interestingly, we found
even for small sample sizes (12 to 15) a good compliance (86 to
95%) between MoR and the results of the non-parametric tests.
For large sample sizes the compliance tends to be excellent even
for semi-informative variables (95 to 100%). We also pursued the
question of whether the part of the 10 semi-informative variables
that was not recognized as informative belongs indeed to the noninformative variables (specificity property). The specificity values
were excellent (100%) in all cases, i.e. irrespective of samples sizes,
sample designs and data structure. Finally, when the 10 selected
variables were like the rest of the non-informative variables,
neither the measure of relevance nor the nonparametric tests

Simulation studies
Provided that the measure of relevance represents a new metric
scale it is absolutely essential to proof whether, and to which
extent, it satisfies the three fundamental properties objectivity,
reliability and validity. To examine these properties we conducted
extensive simulation studies:
Since objectivity of a measure or a metric scale is its ability to
reflect the information contained in the measured objects, we first
simulated situations where 1,000 variables among which 10 are
informative and the rest non-informative have to be compared
between two samples. We consider for the 10 variables three
degrees of information content: high, moderate and negligible.
High informative variables are generally variables whose absolute
amount of biological differences between two samples is higher
than their pooled standard deviation, variables also with a
normalized biological deviation larger than 1. Variables with
normalized biological differences near 1 are semi-informative and
those with normalized biological differences close to 0 noninformative. However, as already mentioned, the normalized
biological differences alone may not describe the relevance of the
variables. One has to also consider the sample sizes to better
analyze the degree of relevance. Therefore, we performed the
PLoS ONE | www.plosone.org
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Objectivity of the measure of relevance for the two sample-problem expressed in sensitivity and specificity indexes. Three two-sample situations were simulated. In each of them 1,000 variables among which 10 were very
informative (normalized biological difference (NBD)&2:0), semi-informative (NBD&1:0) or non-informative (NBD&0:0), respectively. With 200 simulation runs the sensitivity (% correctly identified informative variables) and
specificity (% correctly identified non-informative variables) were determined. Specificity is excellent and with increased normalized biological differences and sample sizes also the sensitivity indexes go up to excellent levels 100%
(for more details see text).
a
Rates (in %) of variables detected as relevant by the MoR.
b
Rates (in %) of variables detected as significant by applying appropriate nonparametric tests.
doi:10.1371/journal.pone.0035741.t001
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Table 1. Objectivity of the measure of relevance.
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only metric data. For the simulation study, we performed 200
simulation runs in each of which 1,000 variables were generated as
described above. To compare the selection quality of the MoR
with the aforementioned methods, we used the sample-related
objective cut-off criterion. Among the three methods applied to the
data, the MoR-method and Student’s t-Test without a-adjustment
indicate excellent and almost identical sensitivity values for
informative and semi-informative variables (see table 3). This
observtion is independent of sample design and size. The Random
Forest shows a weakness of sensitivity in the detection of
informative and semi-informative variables, which can be
explained with the appearance of strong pseudo-correlations
between these variables and some of the 990 non-informative
variables. The specificity values however, which vary from good to
very good for all methods, show some discrepancies between the
Random Forest method and the MoR and multiple-testing
method, especially for large sample sizes. However, this should
not be interpreted as a weakness of the new method.
Among 200 simulation runs, each with normal-distributed
pseudo random numbers for 10 informative and 990 noninformative variables, it is also possible to obtain some large
effects (normalized biological differences) by random among the
non-informative variables. With increasing sample sizes the stop
criterion always becomes smaller, so the risk for obtaining more
non-informative variables with MoR-values larger than the stop
criterion will increase with increasing sample size. They will then
be falsely identified as informative which explains the weak
specificity of the measure of relevance for large samples. In
practice, however, is not advisable to declare variables with small
differences in their group means automatically as non-informative.
Whenever such variables posses a negligible variance in the two
groups as well, they will point to large effects and therefore, should
be declared as informative even if their group mean differences are
small.
We additionally performed a simulation study to investigate
whether the MoR values could be compared, if different data
structures and sample designs are used. Figure (3) depicts Boxgraphs showing the distribution of the measure of relevance based
on these simulations.
The sample size was constant in all samples and all simulations
(n1 ~n2 ~15). The information content was assigned not only to
10 variables but to all considered variables. For independent
samples with metric data the simulated data for one sample was
derived from N(0,1), whereas for the other sample it was derived
from N(k,1) with k~0:0, 1:5 and 3:0 in order to produce
normalized effect sizes equal to 0:0 (non-informative), 1:0 (semiinformative) and 2:0 (informative), respectively. For dependent
samples the simulations were similar to the case with independent
samples, except for a correlation aspect which has been considered
when choosing data for the second sample. Since comparing the
MoR-values of different data types (e.g. metric vs binary) is only
meaningful when the data of different types contain almost similar
information, we created the binary data for both independent and
dependent samples as follows: The metric data of the 1,000
variables were transformed in binary data by giving the values 0
and 1 when data of the two samples were less or greater the wholesample median, respectively. Interestingly, the box graphs
corresponding to the same information contents, except a few
outliers (extremes), do not show any denotative differences
irrespective of data structure and sample design. We can therefore
claim that the measure of significance could be applied in all data
and sample situations without constraints.

detected any informative variables among them. This can be
confirmed by the high specificity values (about 99%), that remain
high for any sample size and design. Overall, the objectivity
property of the measure of relevance is acceptable.
Figure (2a) visualizes the objectivity of the measure of relevance
for simulated metric and binary data of independent and dependent
samples by using small samples (n1 ~n2 ~15). The data generation
in simulations with samples with binary data structure was based on
Bernoulli-distributions B(1,pi ),i~1,2, where pi was selected in such
way that the normalized biological differences equals about 2:00,
1:00 or 0:00. With the pi pairs ½0:81,0:12, ½0:65,0:10 and
½0:50,0:50 for the samples we generated pseudo-random numbers
equal to 1 and 0 having the desired properties. Variables whose
absolute MoR is placed at the beginning of the x-axis have the
largest information content. For both sample designs and both data
structures the ten variables with largest information content
revealed very large MoR-values in comparison to the other
variables; therefore, they were placed at the beginning of the
graph. Application of the sample-related objective cut-off criterion
2:45:h
2:45:0:80
(dj w~ pﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ ~ pﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ ~0:50) clearly revealed
(15z15)=2
(n1 zn2 )=2
these informative variables (see horizontal red lines in the upper).

(b) Reliability
As mentioned above, we have to simulate variables that are
derived from different distributions for testing reliability. Next to
the normal distribution, which was already used to test objectivity
(see table 1), we chose for the variables two other distributions,
namely, a uniform and a bimodal (mixed) distribution. To obtain
the same normalized biological differences with these distributions
as with the normal distribution used in the objectivity considerations, we chose suitable distribution parameters. For example,
since the r
standard
deviation of a uniform distribution U on ½0,1 is
ﬃﬃﬃﬃﬃ
1
~0:288, we have to draw pseudo-random numbers
equal to
12
from a uniform distribution f1 ~3z3:5:U(0,1) for one sample and
a uniform distribution f2 ~0z3:5:U(0,1) for the other in order to
obtain 10 very informative variables with normalized biological
difference of about 2:00.
Table 2 shows the reliability results from the simulation runs.
For the 10 informative or semi-informative variables obeying the
uniform distribution, we obtain results similar to that for the
normal distribution (see table 1) for both sample designs. However,
if the variables follow a bimodal distribution, the rate of detecting
variables as informative is for small samples low, even in the case
of variables with large informative content. This is not surprising.
Variables following a bimodal distribution have large variances
and yield poor mean estimations in small samples. Standardized
mean differences based on these variables are, therefore, also
affected by small samples. The MoR as well as the inferential tests
are more effective in cases of large sample sizes because with large
samples means of differences or effects can be assessed more
accurately. Nevertheless, the sensitivity and specificity of MoR are
large (from 84% to 100%), even in the case of variables with
bimodal distribution. This indicates the excellent diagnostic
capability of it in informative and not-informative situations.

(c) Validity
The aim here is to show that the introduced method, based on
MoR, is at least as good as a classic inferential approach or a wellknown exploratory approach. As already mentioned, we use the
multiple testing and the Random Forest (see [10]) as comparative
approaches. We use for both independent and dependent samples
PLoS ONE | www.plosone.org

8

May 2012 | Volume 7 | Issue 5 | e35741

Identifying Biomarkers in Biomedical Research

Figure 2. Measure of relevance for simulated and authentic data. (a) Courses of the best 100 MoR-values by simulating a two-sample
problem with 1,000 variables of different data types and sample designs. For each variable and each sample n~15 pseudo random numbers
following a certain distribution (see more details in text) were drawn. The three lines correspond to situations with 10 high-informative, semiinformative or non-informative variables among the considered 1,000 variables, respectively; all other (990) variables were non-informative.
Irrespective of data type and sample design the 10 informative variables (blue lines) were correctly identified with MoR. As expected the semi-
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informative variables showed lower MoR-values and were only partially detected as relevant. (b) Application of the MoR approach to sleep EEG data
in order to investigate the effect of sleep deprivation on sleep behavior. n~16 subjects were examined in two nights, before and after sleep
deprivation. Dataset consists of different data types (metric, ordinal, binary etc.). The MoR-values of the parameters over the solid (red) line are all
2:45:h
2:45:0:80
greater than the sample-related cut-off criterion (dj § pﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ ~ pﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ ~0:50).
(n1 zn2 )=2
(16z16)=2
doi:10.1371/journal.pone.0035741.g002

pairs. Since each level pair represents a two-sample situation, the
identification of the biomarker candidates uses exactly the same
procedure presented for the two-sample situation. However, the
biomarkers identified under the various level pairs do not have to
be identical and would probably differ in their amounts and signs.
Depending on the focus of our interest we can thereafter, either
use those identified by a certain level pair or declare all different
biomarkers identified by the various level pairs as overall
biomarker candidates, i.e. as variables characterizing the impact
of the influential factor.
ad 2. The investigation of factor interaction in the case of two or
more influential factors can be done only when the sample sizes
are large. The necessary size of a population sample in such cases
depends on the number of factors considered and their levels.
Assuming, for example, a minimum of 10 items per sample for the
application of MoR in the two-samples situation; then for factors
with more levels it is recommended to use population samples
equal or larger than 10:(k1 zk2 z:::zkr ), where ki is the number
of levels for the factor i, i~1,2,:::,r). The former method is similar
to that used in question (1).
ad 3. This question is more complicated and it addresses
difficult numerical methods. In multivariate problems with, say p
variables, the number Mp of all possible variable interactions is
Mp ~2p . For large p (e.g. p~100), Mp becomes very large and
numerical operations and algorithms towards Mp can not be
computed easily. On the other hand, one has to ask, whether and
which interactions between biomarkers make sense. Generally,
scientists are not too interested in examining on which interactions
of variables the influential factors exercise significant effects. They
want, more or less, to investigate on which variables some
preconceived influential factors and their interaction have a crucial
influence. This point of view brings us back to questions (1) and (2).
When, in high dimension data, interactions make sense, we
recommend investigation of interaction/correlation effects in the
last stage of the analysis, namely, after identifying the most
relevant biomarkers by means of MoR. This method should be
followed under certain conditions, also in the statistical inference
based on multiple testing (see [11]).

(d) Quality and practicability of the objective criteria
Finally, the simulation data and samples used for proving
reliability were also employed to evaluate quality and practicability
of the objective criteria for variable selection across the information chain. As objective criteria we considered those based on
entropy, permutation and on the sample related cut-off formula.
Independent on sample sizes, sample designs and distribution
forms of the data, the three criteria selected the same variables as
relevant, whenever they are indeed informative and differ
substantially from the non-informative variables. Permutationbased criterion and the sample related cut-off criterion supply also
similar results in cases of semi-informative variables. However, for
semi-informative variables the entropy-based criterion shows some
deviations from the others criteria, but this is understandable. If
the MoR of the considered variables are very close across the
information chain the entropy change between neighbor variables
will be almost stable irrespective of the MoR amounts. In such
cases, Dj in inequalition 11 decreases monotonously and with
almost equal decrements between adjacent MoRs and is after
certain steps less than the chosen e. The smaller the chosen e the
more steps will the algorithm need to stop.
As an orientation in handling with the objective criteria for
variable selection with the MoR method is to prevail the following:
The entropy-based criterion can be applied to any sample
amounts. It works better than the other two criteria in cases of
very small samples (n1 ,n2 ƒ10). Values for e between 0:001 and
0:005 seem to be here very good. By large samples also the sample
related cut-off criterion works very well and should be preferred
because of its application simplicity. By moderate samples (n1 ,n2
between 10 and 20) the permutation-based criterion delivers also
acceptable results, but its application is very cumbersome and
computationally intensive. Generally, the establishment of an
unequivocal optimal stop criterion constitutes a further challenge
and an interesting task for the future time.

Some comments to more complex designs
The essence of the above explanation was the two samplesituation problem or, in other words, the multivariate problem
with a single influential factor of two levels only. However, when
studying complex phenomena in basic research, we seldom have
to deal with such simple situations. The designs of basic research
studies are generally more complex. They exhibit more than one
influential factor, some of which may have more than two levels.
Therefore, the following questions have to be addressed: [(1)]

Examples
The following three examples demonstrate the power of this
novel method in identifying relevant biomarkers.
1) Sleep data example. Sleep is a very important component
of life. Therefore, it is of immense relevance to know the
physiology, structure and functional mechanisms of the sleep
process as well the causes of its disturbances. In sleep research
polysomnographic recordings including, electroencephalograms
(EEG), electrocardiograms (ECG) and muscle activity (EMG), are
commonly used. From these recordings a variety of variables
(parameters) are extracted for detailed sleep data analysis. The
resulting parameters may be classified in architecture, continuity
or quantitative parameters representing respectively durations in
the sleep states or transitions between sleep states or rhythmic
intensities of certain frequencies and frequency bands as well.
The objective of a recent study ([12]) was to examine the effect
of sleep deprivation on sleep and the secretion of a specific

1. How can we apply the measure of relevance in more complex
situations (more influential factors or more than two levels)?
2. How can we study interaction effects of two or more influential
factors on multivariate data?
3. Is there a possibility to investigate factor effects on interaction
of biomarkers?
ad 1. For experimental designs incorporating one influential
factor with more than two levels, we consider all possible pair
combinations of these levels. With the MoR method we identify
the most informative variables (biomarker candidates) for all level
PLoS ONE | www.plosone.org
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Prop. of inf. var [%]

S1 : 0:2:N(0,1)z0:8:N(5,1)
S2 : 0:8:N(0,1)z0:2:N(5,1)

Prop. of inf. var [%]

Bimodal distribution

1.00

1.00

1.00

1.00

1.00

1.00

Specificity

Bimodal distribution

0.96

0.92

0.88

0.95

0.90

0.84

1.00

1.00

1.00

1.00

1.00

1.00

Specificity

Sensitivity

1.00

1.00

1.00

1.00

1.00

1.00

30; 30

14; 16

12; 10

30; 30

14; 16

12; 10

Sample Sizes
(n1; n2)

30

15

11

30

15

11

Sample Sizes (n1 = n2)

Specificity

Reliability of the measure of relevance for the two sample-problem expressed in sensitivity and specificity indexes. Two different distributions, uniform and bimodal, were used for evaluating reliability. Like the objectivity also the
reliability property of the relevance measure goes up to excellent levels (sensitivity and specificity about 100%) with increased normalized biological differences and sample sizes.
a
Mean rates (in %) of the variables detected as relevant or significant by MoR.
b
Mean rates (in %) of variables detected as relevant or significant by applying appropriate nonparametric tests.
doi:10.1371/journal.pone.0035741.t002

%1:50

adm:

b) semi-informative variables

%3:00

ƒ2:00

adm:

nbd:

a) very informative variables

Information content of the variables

Dependent Samples

%1:50

adm:

b) semi-informative variables

%3:00

adm:

a) very informative variables

Information content of the variables

Independent Samples

Table 2. Reliability of the measure of relevance.

Identifying Biomarkers in Biomedical Research

May 2012 | Volume 7 | Issue 5 | e35741

Identifying Biomarkers in Biomedical Research

Table 3. Validity of new method compared to alternative methods.

Independent Samples

Method

Sensitivity

Dependent Samples

Specificity

Sample Sizes (n1; n2)

12; 10

Sensitivity

Specificity

Sample Sizes (n1 = n2)

11

a) very informative variables
New Method:

1.00

0.86

1.00

0.82

T-Test without a-adjustment:

1.00

0.95

1.00

0.95

T-Test with a-adjustment:

0.90

1.00

0.90

1.00

Random Forest:

0.30

1.00

0.50

1.00

New Method:

1.00

0.78

1.00

0.69

14; 16

T-Test without a-adjustment:

1.00

0.95

1.00

0.95

T-Test with a-adjustment:

1.00

1.00

1.00

1.00

Random Forest:

0.20

1.00

0.20

1.00

New Method:

1.00

0.56

1.00

0.41

T-Test without a-adjustment:

1.00

0.93

1.00

0.96

T-Test with a-adjustment:

1.00

1.00

1.00

1.00

Random Forest:

0.50

1.00

0.30

1.00

1.00

0.87

1.00

0.81

30; 30

15

30

b) semi-informative variables
New Method:

12; 10

T-Test without a-adjustment:

1.00

0.96

1.00

0.95

T-Test with a-adjustment:

0.00

1.00

0.50

1.00

Random Forest:

0.70

0.99

0.30

1.00

New Method:

1.00

0.74

1.00

0.67

T-Test without a-adjustment:

1.00

0.96

1.00

0.95

T-Test with a-adjustment:

0.70

1.00

0.60

1.00

Random Forest:

1.00

0.90

0.30

1.00

New Method:

1.00

0.59

1.00

0.39

T-Test without a-adjustment:

1.00

0.95

1.00

0.96

T-Test with a-adjustment:

0.90

1.00

1.00

1.00

Random Forest:

1.00

0.98

1.00

0.92

14; 16

30; 30

11

15

30

c) non-informative variables
New Method:

0.10

0.87

0.10

0.81

T-Test without a-adjustment:

0.00

0.96

12; 10

0.00

0.95

T-Test with a-adjustment:

0.00

1.00

0.00

1.00

Random Forest:

0.00

0.98

0.00

1.00

New Method:

0.40

0.75

0.30

0.69

T-Test without a-adjustment:

0.00

0.95

0.00

0.95

T-Test with a-adjustment:

0.00

1.00

0.00

1.00

Random Forest:

0.10

0.97

0.00

1.00

New Method:

0.40

0.57

0.70

0.40

T-Test without a-adjustment:

0.10

0.95

0.00

0.96

T-Test with a-adjustment:

0.00

1.00

0.00

1.00

Random Forest:

0.00

1.00

0.00

1.00

14; 16

30; 30

11

15

30

Validity of the measure of relevance for the two sample-problem evaluated by sensitivity and specificity. For comparisons we used the a multiple-testing-adjusted
approach based on the t-test and the tree-based Random Forest approach. For informative or semi-informative metric data sensitivity showed good concordance with
multiple testing without a-adjustment. This was irrespective of sample design and sample size. Specificity did not show as good results as sensitivity (for more details
see text). However, the specificity results were better than those obtained from t-test without multiple-testing-adjustment.
doi:10.1371/journal.pone.0035741.t003

hormone (Renin) during the recovering night. A sample of n~16
subjects investigated two times (before and after sleep deprivation)
serves as background for the study.
The deprivation study is equivalent to a multivariate two
situation problem with dependent samples and different data
types. Therefore, the question ‘which sleep parameters show
PLoS ONE | www.plosone.org

significant differences between nights before and after sleep
deprivation’ is investigated by our method based on the measure
of relevance. The results are depicted in figure (2b). The graph
represents the ordered MoR values and visualizes the magnitude
of change of the considered sleep parameters after sleep
deprivation. On the right side of the diagram are listed those
12
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Figure 3. Boxplots of the MoR values under diverse sample designs and data structures. Irrespective of data type and sample design in
the two-sample problem, the measure of relevance shows similar values if the variables are very informative (Normalized Biological Difference (NBD)
about 2:0), semi-informative (NBD about 1:0) or non-informative (NBD about 0:0).
doi:10.1371/journal.pone.0035741.g003

for panic disorder (PD), a disease with a lifetime prevalence up to
4% worldwide. To approximate this aim, genome-wide casecontrol association analysis based on about 317,000 SNPs (single
nucleotide polymorphism) across the entire genome were conducted. The study consisted of three stages. In each stage different
samples of the patient- and control-populations were included in
order to consider various aspects of the disease and to verify some
findings. In the first stage, which is of particular interest for the
scope of this paper, case-control association analysis were
performed on 216 PD-patients and 222 controls (discovery
sample). The identified biomarkers were then used in further
stages for identifying and verifying the most significant among
them.
The purpose of the study in each stage can be translated into the
investigation of significant differences in a multivariate two-sample
problem with independent samples and binary data structure. A
common way to do this investigation is to calculate the x2 -statistics
for the allele-frequencies of the considered SNPs and then tested
significance after correction for multiple testing. The investigators
followed this method, but after correction none of the SNP
remained significant in the first stage. They decided however to
select the 64 SNPs with the smallest p-values by the corresponding
x2 -tests as biomarker candidates and to test their relevance in the
other stages. In the second and third stages some SNPs that
showed marginal significance at the corrected a-level in the first
stage pointed to strong significant differences in their allele
frequencies between PD patients and controls. The decision of the
investigators to skip to the other stages proved to be wise. In the
face of statistical inference, however, the changeover from the first
to the other stages is a critical act. We decided to apply the MoR
approach on a fraction of the data used in the first stage of the
study. By randomly choosing two samples of n~50 among the 216
patients and 222 controls and calculating for each of the 317,000

variables which were identified as most relevant by the samplerelated objective cut-off criterion, which in this case
2:45:0:8:
equals pﬃﬃﬃﬃﬃ *0:50. Interestingly, in this study the measure
16
of relevance revealed a lot of significant sleep parameters (20
among 157), which appear to be too much. Nevertheless, we are
not surprised by this result because sleep deprivation provokes
general changes at many of the considered parameters ([12]). With
the MoR approach we endorse again that sleep deprivation is the
most powerful method to promote sleep. During the recovery
night following sleep deprivation sleep propensity is enhanced
resulting in by the architecture parameters (AP) significant
increases of slow wave sleep (SWS), rapid eye movement (REM),
sleep-efficiency index (SEI)and sleep stage 3 and decreases of
shallow sleep (sleep stage 1) and wakefulness. We found also
significant increases after sleep deprivation in some continuity
parameters (CP) like the transition frequencies from wake to light
sleep and from sleep stage 2 to REM sleep as well as significant
decreases in the transitions light sleep to wake. By the quantitative
parameters (QP) the rhythmic intensities of Delta bands (Delta
power) showed during the recovery night significant higher values
than in the baseline. We can say that almost all old findings have
also been found by MoR without any requirements of data
structure, sample size and hypothesis testing which emphasizes the
usefulness of the MoR method in sleep research. Applying the
non-parametric sign-test to variables that were detected as
informative by the MoR, yielded p-values less or equal to the
Bonferroni-adjusted a. Therefore, we can assert here that the sleep
parameters identified as the most relevant by MoR are the best
biomarkers of sleep deprivation.
2) An example with molecular-biology data. In this
example we use data of a published study ([13]). The objective
was to investigate which genes or gene mutations are responsible
PLoS ONE | www.plosone.org

13

May 2012 | Volume 7 | Issue 5 | e35741

Identifying Biomarkers in Biomedical Research

gene expression data between the three lines in the gingulate
cortex region only. Among the 46,657 investigated probes,
applying the MoR method on the normalized expression values
with entropy-based criterion (e~0:001) for variable selection we
detected 29, 30 and 28 probes with very intensive (informative)
regulation differences between HAB and NAB, HAB and LAB as
well as NAB and LAB mice, respectively (see figure (5)). 26 of these
probes were common to all three comparisons. These 26 common
probes correspond to genes being among the 32 top candidates
genes selected by the authors under laborious statistical analyses
for further investigations. Interestingly, all relevant probes
recovered by MoR also belong to the 40 top candidate genes
that have been detected by the authors after application of
multiple testing and Bonferroni corrections on the 46,657 probes.
Via the MoR method we succeeded therefore in finding almost the
same results as with inferential statistics. However, this time
without testing and without any use of significance levels and
corrections. This confirms the quality and application power of the
MoR method for microarray analyses.

SNPs the corresponding measure of relevance we obtain, after
sorting and application of the sample-related cut-off stop criterion
with h~0:50, about 40 SNPs as biomarker candidates. With a few
exceptions all the rest of these 40 SNPs are including in the 64
SNPs that showed marginal significance with the multiple-testing
in the first stage of the study. By illustrating the relevance measures
of the best 200 SNPs (see figure (4)) against chromosome and
distance in 3D format (mountain-valley view) we can see, that
some SNPs, especially on chromosomes 11,12,13,16 and 3, point
to very large MoRs and therefore seem to be the best biomarker
candidates. Two of these SNPs are identical to those identified as
significant in the other stages of the mentioned study. Therefore, if
we had applied MoR in the first stage of the study, the changeover
to the other stages could take place without objection.
3) An example with transcriptomic data. To document
the broad practicability of the MoR method, we provide an
example on gene expression data of microarray analyses carried
out on a small sample size (n~5{6). These data stem from a
recently published work ([14]) carried out to investigate the effects
of anxiety-related behavior on gene expression profiles. By using
mice of three different bred lines characterized by high (HAB),
normal (NAB) and low (LAB) anxiety behavior, the authors of the
study used microarrays to investigate the gene expression profiles
of different brain regions within the limbic system of these mice.
For space reasons we focus our attention on the comparison of the

Discussion
Modern digital and multimedia-based techniques enable an
overabundant gain of information at almost any time and in
almost any situation. In the past few years we have experienced an
overflow of information and are astonished at how quick, precise

Figure 4. Mountain-valley view of the MoR-values corresponding to the most informative SNPs. Identifying genes with relevant
differences in microarray-based expressions between HAB, NAB and LAB mice. Using the MoR method with the entropy-based stop criterion for
variable selection 29, 30 and 28 among 46,657 probes were proven to be very informative (relevant) in their expression profiles between HAB and
NAB (black symbols over the black solid line), HAB and LAB (blue symbols over the blue solid line)and NAB and LAB (red symbols over the red solid
line) mice, respectively. All relevant probes belong to the set of the 32 genes identified and declared with laborious methods from the study
investigators as top candidate genes for further investigations.
doi:10.1371/journal.pone.0035741.g004
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When the vector components are time-dependent or have the
structure of a time series, a good possible method for variable
reduction is functional fit over time. Polynomial or B-splines of a
degree q less than p are applied to the time series and impose
thereby a dimension reduction from p to q. Functional fits show
the same disadvantage as MDS, namely, the estimated components of the q-dimensional vectors are seldom identical to the
original variables.
Another approach to achieve dimension reduction by time- or
not time-dependent data may be obtained by the application of
appropriate association models like generalized linear models,
additive structured regression, functional regression, factor analysis, discriminant analysis, variance analysis etc (see e.g. [16]). In
these models a response variable is usually associated with many
other variables (predictors) and the objective is to explain the
variability of it by the predictors. However, such models are only
appropriate with adequate amounts of predictors, certain data
structures and large samples. Whenever there are too many
observed variables (many hundreds or many thousands) association models should not be applied without further ado. Beside the
risk of collinearity, which would violate basic model assumptions,
the shape of the functional form used is often questionable.
Also, some modern explorative methods such as Random
Forest, LASSO, CART etc. which were developed for classification tasks, may determine the most relevant variables well (for
details see [5]). However, the main principle behind these methods
‘the winner takes it all’ often metabolizes (especially by more than
two classification possibilities) these methods in black boxes where
the output is indeed relevant but not informative enough about the
selected variables. ‘Identifying relevant predictor variables, rather
than only predicting the response by means of some ‘black-box’, is
of interest in many applications’ ([17]). Moreover, in the face of
too many variables the algorithms of these methods involve a risk
of identifying some pseudo-correlations as true correlations. This
fact may bias and distort the results. It is important to also mention
here a weakness of methods that are based on split algorithms:
Variables, which show in two-sample problems negligible differences between the two samples, will not be detected as relevant by
methods based on split algorithms, irrespective of how small the
variance is. This is undesirable for variables with small biological
difference between two populations could be indeed of very large
importance whenever they show small variance. Another disadvantage of those methods is that classification results obtained with
a certain set of variables may be changed when additional
variables have to be added to the set. Considering the sign of the
MoR, our new method enables, in contrast, not only the
identification of relevant biomarkers, but also supplies information
about the degree of relevance and the direction of the differences
between the groups etc.
For high-throughput biomarker discovery some new strategies
exist. They take into consideration possible correlations among the
input variables. One example is the correlation modeling
approach. It translates statistical inference to new data after
modeling correlation structure with a special functional i.e. a
spatial autoregressive model (see [18]). Another interesting
approach uses new test-statistics, which combine the t-scores with
estimated correlations (see [19]). A novel approach in association
analysis is based on the correlation-adjusted t’-scores, which give
optimal rankings in the t-scores when variables are correlated (see
[20]). Nevertheless, all these methods work well with metric data
but can not be transferred to other types of data without difficulties
or strong compromises. We should again keep in mind that the
investigation of group effects on variable interactions is not the
same as searching for possible correlations between dependent

Figure 5. Measure of relevance for gene expression data.
Application of the MoR approach to molecular biological data (SNPs) for
identifying SNPs with relevant differences in the allele frequencies
between controls and patients with panic disorder. In each group the
SNP-data of n~50 subjects were examined. For the two-independentsample problem on hand with binary data the MoR-values of three SNPs
on the chromosomes 10, 11 and 12 showed MoR-values above the sample2:45:h
2:45:0:50
related cut-off criterion (dj § pﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ ~ pﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ ~0:17).
(50z50)=2
(n1 zn2 )=2
doi:10.1371/journal.pone.0035741.g005

and opulent this information is. Meanwhile, this trend is also found
in research laboratories of almost all scientific disciplines. As stated
in the introduction, any additional information about a phenomenon may contribute to a better explanation of it, but concurrently
complicates the understanding and interpretation of its functions
and mechanisms. For example, if the investigated phenomenon is
a complex disease like major depression, the understanding of its
genesis and synthesis requires abundant information on many
levels (e.g. neuro-endocrinological, physiological, molecular-biological etc.). However, for therapy of the disease we want to know
the most relevant influential factors, because the fewer the relevant
factors, the better the treatment efficiency. Therefore, data
shrinkage based on a reduction of dimension is the solution. But
attention has to be paid so that loss of information is kept low.
One method of dimension reduction are the multidimensional
scaling (MDS)-methods used in mapping and other visualization
techniques (see [15]). Based on a distance matrix determined by a
certain distance measures (e.g. the Euclid or Mahalanobis
distance), multidimensional scaling is targeted to project pdimensional to q-dimensional vectors (qvvp) with minimal
information loss. Factor analysis or principal component analysis
are special applications of MDS-methods. One disadvantage of the
MDS is, that components of the new vectors are expressed more
or less as compounds of the components of the old vectors and
can, therefore, be seldom identical with the original variables.
Another problem is caused by the definition and use of distance
measures. Since distance measures are determined over all vector
components, object pairs often show the same distance values
although their components are completely different. Hence MDStechniques are not optimal for biomarker searching.
PLoS ONE | www.plosone.org
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variables in order to perform multiple testing more correctly. An
interesting method for testing group effects on gene interactions
(occasionally called epistatic interactions) is given by [21].
Our simulation studies revealed that the new method is at least
as efficient as alternative approaches. However, in comparison to
the alternatives, the new method for biomarker searching has
some noteworthy advantages: First, it is free from association
forms or functionals between response variable and predictors.
Second, is free of classification risks, which are caused by pseudocorrelations in the case of high-dimensional data. Third, it
operates on the explorative level and needs no correction of the
level of significance for the identification of the best biomarkers.
Fourth, it works well for any kind of experimental design and data.
Last, but not least, it is very easy to apply.
It would be very interesting to investigate the robustness of
MoR towards the weaknesses characterized by drawing multivariate samples in practice (e.g. poor representativeness, collinearity
and dependency, outliers, mixed data structures, stratification,
etc.). Of course the use of ranks provide an excellent basis for
neutralizing outliers and different data-types, but as to whether it
may also flatten some other troublesome effects is not clear. A
good possibility for attenuating intrasampling weakness and
simultaneously obtaining robust estimators and confidence intervals of the MoR is provided by bootstrap sampling. Based on a
random sampling, with replacement from the original sample, the
desired number of resamples from the original data can be
created. By calculating for each resample the MoR of the
considered variables we can create for each variable as many
MoRs as desired. Estimators and confidence intervals of the
expected MoR can then easy determined.
Nevertheless, by all advantages of MoR we must not forget, that
it acts and operates on an explorative level. Therefore results
obtaining by MoR should be rather considered as trend-settings

and not as ultima ratios. In the face of its comfortable applicability
we plead to use MoR predominantly as an orientation and
navigation tool in the prefields of basic research studies. After
detecting with it the most relevat biomarker candidates study
replications focused on all or part of these biomarkers are then
recommended.
However, the method is still in progress. We are investigating
the possibility to implement interactions, especially epistatic
interactions of two, three and larger degrees. Also, we are trying
to further optimize the selection criteria. Nevertheless, given that
for each variable the relationship between the information content
and amount of MoR is unequivocal, the failure of an optimal
selection criterion should not be considered as an essential
impediment. By choosing from the (increasing) information chain
the last k MoRs, we should be sure that the corresponding
variables are also the most informative. And that is enough for the
start of a new method.
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